Kercheville Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,250
| Closed | -$452K | – | 97 |
|
|
2024
Q4 | $452K | Sell |
5,250
-1,200
| -19% | -$103K | 0.18% | 63 |
|
|
2024
Q3 | $768K | Sell |
6,450
-500
| -7% | -$59.5K | 0.32% | 49 |
|
|
2024
Q2 | $992K | Buy |
6,950
+500
| +8% | +$71.4K | 0.43% | 39 |
|
|
2024
Q1 | $828K | Buy |
6,450
+900
| +16% | +$116K | 0.39% | 44 |
|
|
2023
Q4 | $574K | Sell |
5,550
-1,850
| -25% | -$191K | 0.32% | 43 |
|
|
2023
Q3 | $673K | Buy |
+7,400
| New | +$673K | 0.43% | 41 |
|